Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Northwestern Medicine researchers are co-investigators in a breakthrough clinical trial that found transplanted human islets prevent hypoglycemic events and provide excellent glycemic control for patients with Type 1 diabetes with severe hypoglycemia. The results of the multi-center, single arm, phase III study are published in Diabetes Care. The research was funded by National Institute of Health (NIH) grants through the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute for Diabetes and Digestive and Kidney Disease (NIDDK).
Islet transplantation is an investigational therapy for individuals with Type 1 diabetes in which insulin-producing cells, or islets, from a donor pancreas are transplanted into another person. In patients with diabetes, the pancreas does not properly produce insulin. Using a minimally invasive radiologic technique, islet transplantation infuses working cells that can control blood glucose and possibly eliminate the need for insulin therapy. Islets begin to release insulin soon after transplantation with increased function occurring over time.
https://www.sciencedaily.com/releases/2016/05/160502164823.htm
I thought they'd been doing islet cell transplants for ages
Islet transplantation is an investigational therapy for individuals with Type 1 diabetes in which insulin-producing cells, or islets, from a donor pancreas are transplanted into another person. In patients with diabetes, the pancreas does not properly produce insulin. Using a minimally invasive radiologic technique, islet transplantation infuses working cells that can control blood glucose and possibly eliminate the need for insulin therapy. Islets begin to release insulin soon after transplantation with increased function occurring over time.
https://www.sciencedaily.com/releases/2016/05/160502164823.htm
I thought they'd been doing islet cell transplants for ages